Skip to content


Galvus, Jalra, Xiliarx (vildagliptin) is a small molecule pharmaceutical. Vildagliptin was first approved as Galvus on 2007-09-25. It has been approved in Europe to treat type 2 diabetes mellitus. The pharmaceutical is active against dipeptidyl peptidase 4.
Trade Name Galvus, Jalra, Xiliarx
Common Name Vildagliptin
Indication type 2 diabetes mellitus
Drug Class Dipeptidyl aminopeptidase-IV inhibitors
Get full access now